Severe Hypokalemia With Rhabdomyolysis—A Case Report Authors: Tahir Shahzad, Alexandra Murray Published: 2026 ABSTRACT ABSTRACTMagnesium administration should be considered in severe or refractory hypokalemia with even normal serum magnesium; however, more research is needed to establish the evidence and take into account confounding factors. Severe hypokalemia can manifest with rhabdomyolysis, which can affect kidney function. Serum potassium value underscores total body potassium depletion since a major fraction of potassium is intracellular.Keywords: emergency medicine, endocrinology and metabolic disorders, nephrology, pharmacology and pharmacy Introduction Hypokalemia is defined as serum potassium levels less than 3.5 mmol/L, and it has been more prevalent in the United States (US) from 1999 to 2016 [1]. The clinical manifestations of hypokalemia are variable and subtle, with symptomatology depending on severity and onset. Severe hypokalemia, which is defined as serum potassium levels less than 2.5 mmol/L, can manifest with muscle weakness, paralysis, muscle necrosis, and respiratory weakness due to diaphragm involvement and cardiac dysrhythmias. The most common EKG findings in hypokalemia are flattened T waves, ST‐segment depression, and U waves. Rhabdomyolysis and acute kidney injury are rare complications of severe hypokalemia [2, 3]. This case highlights a rare presentation of hypokalemia with rhabdomyolysis and acute kidney injury. Case Presentation A 34‐year‐old Caucasian male presented to a rural emergency department with bilateral hip and thigh weakness that had been ongoing for the last 5–6 days. According to the patient, he received a call from his primary care physician (PCP) to go to a nearby emergency room for profound hypokalemia, which was found in a laboratory workup done earlier that day as an outpatient. He was known to have hypertension; he had tried four different antihypertensives over the past few weeks, started initially on Amlodipine, then changed to Losartan, Lisinopril, and most recently started on monotherapy with Chlorthalidone with poor blood pressure control. He was started on oral and IV potassium replacement therapy, and arrangements were being made to transfer him to a higher care facility, but he left against medical advice. Upon arrival at our emergency department, the patient's GCS was 15, and he was sitting comfortably in bed, moving all four limbs, speaking clearly, and showing no signs of respiratory distress. He denied nausea, vomiting, diarrhea, fever, upper respiratory symptoms, chest pain, diaphoresis, shortness of breath, vision changes, headache, abdominal pain, or numbness or tingling in the arms or legs. Initial vital signs were as follows (Table 1). No previous history of low potassium and no significant family history. He smokes cigarettes and denies drinking alcohol on a daily basis with the last drink about a week ago. The physical exam was unremarkable without any focal neurologic deficits or signs of compartment syndrome. Lung auscultation revealed no added sounds, and the pulse was regular and of normal rate. Power 5/5 in all 4 limbs with normal coordination. TABLE 1Vital signs upon arrival to ED.Non‐invasive blood pressure (mmHg)Heart rate (BPM)Oxygen saturationTemperature (F)Respiratory rateWeight (kg)Height (cm)BMI (kg/m2)169/11971100%98.31888.5175.328.78 Vital signs upon arrival to ED. Differential Diagnosis, Investigations, and Treatment Laboratory results from his outpatient blood work, from the rural emergency department, and our emergency department were markedly abnormal. He had acute kidney injury, rhabdomyolysis, and undetectable potassium levels on multiple labs drawn despite IV and oral replacement. The critical labs from all 3 facilities are outlined below (Table 2). Patient's hip and thigh weakness gradually improved with magnesium and potassium supplementation with otherwise no other complaints during hospital stay. TABLE 2Lab values.LabsFacilityDate; timeResultsReference rangeSodiumTiffin Hospital11/7/25;1313145 mmol/L136–145 mmol/LPotassiumTiffin Hospital11/7/25;1313 < 1.5 mmol/L 3.7–5.3 mmol/LChlorideTiffin Hospital11/7/25;1313102 mmol/L98–107 mmol/LBicarbonateTiffin Hospital11/7/25;131331 mmol/L20–31 mmol/LGlucoseTiffin Hospital11/7/25;1313 116 mg/dL 74–99 mg/dLCreatinineTiffin Hospital11/7/25;1313 1.8 mg/dL 0.7–1.2 mg/dLMagnesiumTiffin Hospital11/7/25;13132.1 mg/dL1.6–2.6 mg/dlTotal BilirubinTiffin Hospital11/7/25;13131.5 mg/dL0–1.2 mg/dlHigh Sensitivity TroponinTiffin Hospital11/7/25;1313 152 ng/L 0–22 ng/LCreatinine Kinase (CK)Tiffin Hospital11/7/25;1313 3009 U/L 39–308 U/LHigh Sensitivity TroponinTiffin Hospital11/7/25;1441 186 ng/L 0–22 ng/LHigh Sensitivity TroponinTiffin Hospital11/7/25;1601 177 ng/L 0–22 ng/LCKTiffin Hospital11/7/25;2110 2287 U/L 39–308 U/LMyoglobinTiffin Hospital11/7/25;2110 1211 U/L 28–72 U/LPotassiumSt Vincent Medical Center11/8/25;0155 < 1.5 mmol/L 3.7–5.3 mmol/LCreatinineSt Vincent Medical Center11/8/25;0155 1.6 mg/dl 0.7–1.2 mg/dlCKSt Vincent Medical Center11/8/25;0155 3013 U/L 39–308 U/LMyoglobinSt Vincent Medical Center11/8/25;0155 1324 U/L 28–72 U/LSerum OsmolalitySt Vincent Medical Center11/8/25;0155296 mOsm/kg275–295 mOsm/kgTSHSt Vincent Medical Center11/8/25;01552.02 mIU/mL0.2–4.2 mIU/mlHigh Sensitivity TroponinSt Vincent Medical Center11/8/25;0155 185 ng/L 0–22 ng/LNT‐Pro‐BNPSt Vincent Medical Center11/8/25;0155184 pg/mL0–125 pg/mLAldosterone (Supine)St Vincent Medical Center11/8/25;0743 40.2 ng/dL < 16 ng/dL (Supine)ReninSt Vincent Medical Center11/8/25;08490.1 ng/mL/h0.2–1.6 ng/mL/h (Supine) Note: Bold indicates abnormal values. Lab values. Note: Bold indicates abnormal values. The patient had a transthoracic echocardiogram (ECHO) completed in the rural emergency department prior to transfer, which showed an ejection fraction (EF) of 60%–65% with normal wall motion and valvular function. There was no pericardial effusion noted on the ECHO. Troponin levels were initially elevated with non‐ischemic EKG findings (Figure 1). He was given 40 mEq oral and 40 mEq intravenous potassium before transfer to our emergency department. Upon arrival, the patient's potassium was less than 1.5 mmol/L. He denied central venous access and consented for oral and peripheral access. He was given another 40 mEq of oral and 40 mEq of intravenous potassium, in addition to 2 g of intravenous magnesium, while in the emergency department. Electrocardiogram (EKG). The patient was subsequently admitted to the medical intensive care unit (MICU) for continued potassium replacement and monitoring. Nephrology was consulted for hypokalemia, rhabdomyolysis, and acute kidney injury. Rhabdomyolysis was managed with intravenous fluids, and serial CK and myoglobin levels trended down. The patient was given 160 mEq of IV potassium and 80 mEq of oral potassium in the MICU and was later transferred to a stepdown unit. The patient was started on Hydralazine, Spironolactone, and Carvedilol for blood pressure control in the hospital. Eventually, he left against medical advice from the stepdown unit with normalized potassium levels (Figure 2) and improving kidney function. Pictogram. Discussion Potassium is a predominantly intracellular electrolyte, with only 2% of potassium residing in the extracellular space [4]. Potassium levels are mainly regulated by the kidneys and are influenced by other electrolytes and acid–base balance. The role of supplementing magnesium in the setting of severe hypokalemia, when total serum magnesium levels are normal, remains debated. Magnesium plays a critical role in regulating potassium through multiple pathways, including the sodium potassium adenosine triphosphatase (Na‐K ATPase) pump and Renal Outer Medullary Potassium (ROMK) channels [5]. As a result of these pathways, magnesium deficiency can contribute to severe and refractory hypokalemia [6]. Furthermore, occult intracellular hypomagnesemia can go undetected because less than 1% of total body magnesium resides within the serum [7]. An ionized magnesium level is a more accurate measurement when compared to a total magnesium level because ionized magnesium is the electrophysiologic active molecule that represents 49%–73% of extracellular magnesium [8, 9]. Unfortunately, ionized magnesium levels are not commonly available. There is also limited literature that suggests that magnesium should be replenished to maintain a high normal range between 2.8 and 3 mg/L [10]. In this case, magnesium was within normal limits, and the patient was given potassium initially with no improvement. After magnesium was administered, potassium levels began to normalize, suggesting that co‐administering magnesium, even when total serum magnesium is normal, is important when treating severe hypokalemia [11]. The literature also contains limited evidence linking severe hypokalemia to rhabdomyolysis [12]. However, in this case, the patient experienced rhabdomyolysis without any other identifiable cause except for severe hypokalemia leading to acute kidney injury. Contracting muscles usually release potassium into interstitial fluid which induces arteriolar dilation and maintain blood supply according to demand; However, in severe hypokalemia the lack of this mechanism that trigger muscle ischemia and necrosis resulting in rhabdomyolysis [13]. One of the possible underlying causes of hypertension and hypokalemia is hyperaldosteronism. Aldosterone stimulates sodium and water retention at the expense of potassium excretion, resulting in hypertension and hypokalemia [14]. Hyperaldosteronism is typically diagnosed with a 2‐step approach. Patients who have resistant hypertension and an aldosterone to renin ratio (ARR) greater than 30 are considered positive [15]. Our patient's ARR was 402, which meets criteria for hyperaldosteronism. Primary hyperaldosteronism as the cause of severe hypokalemia was suspected based on the markedly elevated ARR, but definitive outpatient confirmation is pending. Conclusion and Results This case highlights the potential importance of co‐administering magnesium and potassium in cases of severe hypokalemia despite normal serum magnesium. However, further research is needed to clarify the role of magnesium in correcting hypokalemia in the presence of normal serum magnesium levels. This case also demonstrates how rhabdomyolysis can manifest as a complication of severe hypokalemia. Furthermore, hyperaldosteronism should be considered in patients with refractory hypertension and hypokalemia when alternative etiologies have been ruled out. Author Contributions Tahir Shahzad: conceptualization, methodology, writing – original draft, writing – review and editing. Alexandra Murray: visualization, writing – original draft, writing – review and editing. Funding The authors have nothing to report. Consent Written informed consent from the patient was obtained for publication according to journal guidelines. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement Data sharing not applicable to this article as no datasets were generated or analysed during the current study. References Associated Data Data Availability Statement Data sharing not applicable to this article as no datasets were generated or analysed during the current study.